ATH 33.3% 0.4¢ alterity therapeutics limited

Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-101

  1. 1,086 Posts.
    lightbulb Created with Sketch. 103
    Just abit surprised given the amount of shares on offer, why add such a small handful in...but are these options ?
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.